Cargando…

Insight and Psychosis

Detalles Bibliográficos
Autor principal:	Reddy, M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649806/ https://www.ncbi.nlm.nih.gov/pubmed/26664072 http://dx.doi.org/10.4103/0253-7176.162909

Ejemplares similares

Attenuated Psychosis Syndrome
por: Reddy, M. S.
Publicado: (2014)

Psychosis and Gender
por: Ochoa, Susana, et al.
Publicado: (2012)

Eyes, the window on psychosis?
por: Shoham, Natalie, et al.
Publicado: (2022)

Advances in the Diagnosis and Management of Psychosis
por: Stoyanov, Drozdstoy
Publicado: (2023)

Psychopharmacology and Biological Studies of Psychosis
por: Siwek, Marcin, et al.
Publicado: (2023)

The access and waiting-time standard for first-episode psychosis: an opportunity for identification and treatment of psychosis risk states?
por: Whale, Richard, et al.
Publicado: (2017)

The psychosis continuum: diagnosis and other phenotypes
por: Möller, H. J., et al.
Publicado: (2011)

Back to Basics: Improving Care for Psychosis
por: Steingard, Sandra
Publicado: (2020)

New Opportunities and Challenges of Early Psychosis
por: Rapado-Castro, Marta
Publicado: (2022)

Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis
por: Ham, Suji, et al.
Publicado: (2017)

Recent Neurobiological Insights into the Concept of Insight in Psychosis
por: Mythri, Starlin Vijay, et al.
Publicado: (2016)

A hopeful tale from the wonderland of psychosis
por: Royal, Berenice
Publicado: (2015)

Lack of Insight in Psychiatric Illness: A Critical Appraisal
por: Reddy, M. S.
Publicado: (2016)

Methamphetamine-associated psychosis: a new health challenge in Iran
por: Alam mehrjerdi, Zahra, et al.
Publicado: (2013)

From generation of biomarkers to treatment and psychosocial aspects of psychosis
por: Falkai, P., et al.
Publicado: (2011)

Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
por: Tampi, Rajesh R, et al.
Publicado: (2019)

Clusters of psychosis: compensation as a contributor to the heterogeneity of schizophrenia
por: Palaniyappan, Lena
Publicado: (2023)

Insight and Dissociation in Lucid Dreaming and Psychosis
por: Voss, Ursula, et al.
Publicado: (2018)

Cognitive Impairments and Rehabilitation in Individuals with at-Risk Mental State for Psychosis
por: Nemoto, Takahiro
Publicado: (2023)

Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
por: Rubio, Jose M., et al.
Publicado: (2017)

Insight in Psychosis: An Indicator of Severity of Psychosis, an Explanatory Model of Illness, and a Coping Strategy
por: Jacob, K. S.
Publicado: (2016)

Psychosis research in Asia: advantage from low prevalence of cannabis use
por: Lee, Tae Young, et al.
Publicado: (2016)

Decoding psychosis: from national genome project to national brain project
por: Sun, Liya, et al.
Publicado: (2022)

Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic
por: Aubignat, M.
Publicado: (2021)

Insight and illness perception in Mexican patients with psychosis
por: Gómez-de-Regil, Lizzette
Publicado: (2015)

Anticipating DSM-V: Should Psychosis Risk Become a Diagnostic Class?
por: Carpenter, William T.
Publicado: (2009)

Clinical high risk for psychosis provides new opportunities for schizophrenia intervention strategies
por: Wang, Jijun, et al.
Publicado: (2022)

First episode psychosis and beyond: much progress made but much more needed
por: Suetani, Shuichi, et al.
Publicado: (2023)

Emerging synthetic cannabinoids and the risk of psychosis: a growing concern for public health
por: Souza, José Diogo R., et al.
Publicado: (2023)

Stigma, insight and social anxiety in first episode patients with psychosis
por: Efthimiou, M., et al.
Publicado: (2021)

The right occipital lobe and poor insight in first-episode psychosis
por: Tordesillas-Gutierrez, Diana, et al.
Publicado: (2018)

Insights into psychosis risk from leukocyte microRNA expression
por: Jeffries, C D, et al.
Publicado: (2016)

Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap
por: Schwarz, Emanuel, et al.
Publicado: (2020)

Insight dimensions and cognitive function in psychosis: a longitudinal study
por: Cuesta, Manuel J, et al.
Publicado: (2006)

Narrative insight in psychosis: The relationship with spiritual and religious explanatory frameworks
por: Marriott, Michael R., et al.
Publicado: (2018)

Thyroid Storm Presenting as Psychosis
por: Desai, Dimpi, et al.
Publicado: (2018)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
por: Pollak, Thomas A., et al.
Publicado: (2018)

It is time to start taking tobacco seriously as a risk factor for psychosis: self‐medication cannot explain the association
por: MacCabe, J. H.
Publicado: (2018)

Adapting cognitive behavioural therapy for adolescents with psychosis: insights from the Managing Adolescent first episode in psychosis study (MAPS)
por: Langman-Levy, Amy, et al.
Publicado: (2022)

Self-stigma and cognitive insight in individuals at ultra-high risk for psychosis
por: Sportel, Bouwina Esther, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4g7lkbfmhpurhors41060o236l